Figure 1.
Flow diagram of selecting included studies.
Table 1.
Main characteristics of included studies.
Table 2.
Methodical assessment of RCT studies.
Table 3.
Methodical assessment of non-RCT studies.
Figure 2.
Forest plot for HBV DNA suppression rates 24 weeks post therapy.
Figure 3.
Forest plot for HBV DNA suppression rates 48 weeks post therapy.
Figure 4.
Forest plot for ALT normalization rates 24 weeks post therapy.
Figure 5.
Forest plot for ALT normalization rates 48 weeks post therapy.
Figure 6.
Forest plot for HBeAg seroconversion rates 24 weeks post therapy.
Figure 7.
Forest plot for HBeAg seroconversion rates 48 weeks post therapy.
Table 4.
Sensitivity analysis for the 48 weeks HBV DNA suppression rate.